Insulin Management System RTP Company End-Use Case Study Multiple Thermoplastic Materials Selected for Insulin Management System More than 194 million people worldwide have diabetes, and the World Health Organization expects the number of cases to reach 366 million by the year 2030. Diabetes is a chronic, life-threatening disease characterized by the failure of the body to produce or properly utilize insulin, a hormone that regulates blood glucose. One highly effective method of treating Type I diabetes is Continuous Subcutaneous Insulin Infusion (CSII). However, with conventional insulin pump technology, CSII therapy is complicated, costly, and inconvenient. Insulet Corporation, a leading diabetes management company, has designed the OmniPod® Insulin Management System. This innovative pro

Join for free to read